Parkinsonism-hyperpyrexia syndrome not related to antiparkinsonian treatment withdrawal during the 2003 summer heat wave [1]

Journal of Neurology

Volumn 252, Issue 9, 2005, Pages 1116-1119

  Gaig, Carles ^a   Martí, Maria J ^a   Tolosa, Eduard ^a   Gómez Choco, Manuel J ^a   Amaro, Sergio ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; CREATINE KINASE; DANTROLENE;

AGED; BLOOD EXAMINATION; BLOOD PRESSURE; CASE REPORT; ENVIRONMENTAL TEMPERATURE; FEMALE; FOLLOW UP; HUMAN; HYPOTHALAMUS; LETTER; MALE; MORTALITY; NEUROLEPTIC MALIGNANT SYNDROME; NIGRONEOSTRIATAL SYSTEM; PRIORITY JOURNAL; URINALYSIS;

AGED; ANTIPARKINSON AGENTS; BROMOCRIPTINE; DANTROLENE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER OF UNKNOWN ORIGIN; HEAT STROKE; HUMANS; INFECTION; MALE; MUSCLE RELAXANTS, CENTRAL; NEUROLEPTIC MALIGNANT SYNDROME; PARKINSONIAN DISORDERS;

EID: 25144483854     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-005-0798-8     Document Type: Letter

References (15)

1. Sechi GP, Tanda F, Mutani R (1984) Fatal hyperpyrexia after withdrawal of levodopa. Neurology 34:249-251
2. Granner MA, Wooten GF (1991) Neuroleptic malignant syndrome or parkinsonism hyperpyrexia syndrome. Semin Neurol 11:228-235
3. Takubo H, Harada T, Hashimoto T, Ynaba Y, Kanazawa I, Kuno S, Mizuno Y, Mizuta E, Murata M, Nagatsu T, Nakamura S, Yanagisawa N, Narabayashi H (2003) A collaborative study on the malignant syndrome in Parkinson's disease and related disorders. Parkinsonism Relat Disord 9(Suppl 1):31-41
4. Harada T, Mitsuoka K, Kumagai R, Murata Y, et al. (2003) Clinical features of malignant syndrome in Parkinson's disease and related neurological disorders. Parkinsonism Relat Disord 9(Suppl 1):15-23
5. Ueda M, Hamamoto M, Nagayama H, Okubo S, et al. (2001) Biochemical alterations during medication withdrawal in Parkinson's disease with and without neuroleptic malignant-like syndrome. J Neurol Neurosurg Psychiatry 71:11-113
6. Levenson JL (1985) Neuroleptic malignant syndrome. Am J Psychiatry 142:1137-1145
7. Luterbacher J, Dietrich D, Xoplaki E, Grosjean M, Wanner H (2004) European seasonal and annual temperature variability, trends, and extremes since 1500. Science 300:1499-1503
8. Bouchama A (2004) The 2003 European heat wave. Intensive Care Med 30:1-3
9. Martínez Navarro F, Simón-Soria F, López-Abente G (2004) Evaluation of the impact of the heat wave in the summer of 2003 on mortality. Gac Sanit 18(Suppl 1):250-258
10. Bouchama A, Knochel JP (2002) Heat Stroke. N Engl J Med 346:1978-1988
11. Kuno S, Mizuta E, Yamasaki E (1997) Neuroleptic malignant syndrome in parkinsonian patients: risk factors. Eur Neurol 38(Suppl 2):56-59
12. Hashimoto T, Tokuda T, Hanyu N, Tabata K, Yanagisawa N (2003) Withdrawal of levodopa and other risk factors for malignant syndrome in Parkinson's disease. Parkinsonism Relat Disord 9(Suppl 1):35-30
13. Cao L, Katz RH (1999) Acute hypernatremia and Neuroleptic malignant syndrome in Parkinson Disease. Am J Med Sci 318:67-68
14. Sechi GP, Manca S, Deiana GA, et al. (1996) Acute hyponatremia and Neuroleptic malignant syndrome in Parkinson Disease. Prog Neuro-Psychopharmacol and Biol Psychiatry 20:533-542
15. Easterling DR, Meehl GA, Parmesan C, Changnon SA, Karl TR, Mearns LO (2000) Climate extremes: observations, modeling, and impacts. Science 289:2068-2074